The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases.

CONCLUSION: Despite the poor outcomes with ICI treatment in patients with advanced and recurrent NSCLC who had liver metastasis, some characteristics among patients with liver metastasis may be associated with prognosis.
PMID: 31828427 [PubMed - indexed for MEDLINE]

Source: Clinical Lung Cancer - February 29, 2020 Category: Cancer & Oncology Authors: Kitadai R, Okuma Y, Hakozaki T, Hosomi Y Tags: J Cancer Res Clin Oncol Source Type: research